Authors
Loading...
Meta-analysis demonstrates poorer survival outcomes in patients with elevated bone marrow plasma cell percentage in AL amyloidosis, suggesting improved risk stratification.
Nie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: